DURATION-5: Exenatide Once Weekly Resulted in Greater Improvements in Glycemic Control Compared with Exenatide Twice Daily in Patients with Type 2 Diabetes - Concepedia

Concepedia

Publication | Open Access

DURATION-5: Exenatide Once Weekly Resulted in Greater Improvements in Glycemic Control Compared with Exenatide Twice Daily in Patients with Type 2 Diabetes

DOI Full Paper Access

442

Citations

34

References

2011

Year

Thomas Blevins, John Pullman, Jaret Malloy, Ping Yan, Kristin Taylor, Christine T. Schulteis, Michael Trautmann, Lisa A. Porter

The Journal of Clinical Endocrinology & Metabolism

Abstract

Continuous glucagon-like peptide-1 receptor agonism with ExQW resulted in superior glycemic control, with less nausea, compared with ExBID in patients with type 2 diabetes. Both groups lost weight.

References

	Year	Citations

Page 1